RadNet Inc (RDNT)
RadNet, Inc. is a NASDAQ-listed common stock issuer in the healthcare sector. Through its subsidiaries, the company provides outpatient diagnostic imaging services in the United States and internationally. Its operations are organized into two segments: Imaging Centers and Digital Health. RadNet’s imaging services include MRI, CT, PET, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, along with multi-modality imaging services. The company also develops and sells digital imaging and picture archiving and communications systems, as well as related software and services. In addition, RadNet develops AI-based tools designed to support radiologist interpretation of breast, lung, and prostate images, prostate cancer screening solutions, and health informatics products aimed at improving imaging and radiology operations, efficiency, and outcomes. Founded in 1981, RadNet is headquartered in Los Angeles, California.
Jump directly to the stock analysis sections supported by the latest available data.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Dividend Yield | Next Earnings Date | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-RDNT
|
$51.77
|
-31.9% Downside
|
Overvalued
|
$94.63
|
24.5% Upside
|
Undervalued
|
Good
|
0.0%
|
November 11, 2026
|
5.6x
|
2.7x
|
5.981 B
|
7.742 B
|
25.7%
|
83.5%
|
2.3
|
-342.7%
|
